.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chubb
Covington
Baxter
US Department of Justice
Citi
Cantor Fitzgerald
Boehringer Ingelheim
Express Scripts
Moodys

Generated: November 21, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: tavaborole

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Anacor Pharms Inc
KERYDIN
tavaborole
SOLUTION;TOPICAL204427NDAPharmaDerm, A division of Fougera Pharmaceuticals Inc.10337-905-101 BOTTLE, WITH APPLICATOR in 1 CARTON (10337-905-10) > 10 mL in 1 BOTTLE, WITH APPLICATOR
Anacor Pharms Inc
KERYDIN
tavaborole
SOLUTION;TOPICAL204427NDAPharmaDerm, A division of Fougera Pharmaceuticals Inc.10337-905-441 BOTTLE, WITH APPLICATOR in 1 CARTON (10337-905-44) > 4 mL in 1 BOTTLE, WITH APPLICATOR
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Merck
McKinsey
Daiichi Sankyo
Chubb
McKesson
Healthtrust
Chinese Patent Office
Cerilliant
Teva

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot